Erasca to Present at the Bank of America Securities Health Care Conference
Erasca, a clinical-stage precision oncology company focused on developing therapies targeting RAS/MAPK pathway-driven cancers, announced it will present at the Bank of America Securities 2026 Health Care Conference, with management participating in a fireside chat and investor meetings. The company highlighted its mission to create novel cancer the…